Cargando…
Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial
OBJECTIVE: To compare effects of combinations of standard and intensive treatment of glycemia and either blood pressure (BP) or lipids in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. RESEARCH DESIGN AND METHODS: ACCORD enrolled 10,251 type 2 diabetes patients aged 40–79 year...
Autores principales: | Margolis, Karen L., O’Connor, Patrick J., Morgan, Timothy M., Buse, John B., Cohen, Robert M., Cushman, William C., Cutler, Jeffrey A., Evans, Gregory W., Gerstein, Hertzel C., Grimm, Richard H., Lipkin, Edward W., Narayan, K.M.Venkat, Riddle, Matthew C., Sood, Ajay, Goff, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030092/ https://www.ncbi.nlm.nih.gov/pubmed/24595629 http://dx.doi.org/10.2337/dc13-2334 |
Ejemplares similares
-
Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD
por: Shah, Hetal S., et al.
Publicado: (2018) -
Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial
por: Morieri, Mario Luca, et al.
Publicado: (2018) -
Dysglycemia and a History of Reproductive Risk Factors
por: McDonald, Sarah D., et al.
Publicado: (2008) -
A Type 2 Diabetes Subtype Responsive to ACCORD Intensive Glycemia Treatment
por: Mariam, Arshiya, et al.
Publicado: (2021) -
Value of Urinary Albumin-to-Creatinine Ratio as a Predictor of Type 2 Diabetes in Pre-Diabetic Individuals
por: Friedman, Allon, et al.
Publicado: (2008)